Clinical Trials Browser

Phase NA × Pancreatic Neoplasms × sintilimab × Clear all

NCT06353646 2026-02-13

XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer

Phase NA Recruiting

Gastrointestinal

Pancreatic Neoplasms